Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Stine Karlsen"'
Autor:
Stine Karlsen Oversoe, Michelle Simone Clement, Britta Weber, Henning Grønbæk, Stephen Jacques Hamilton-Dutoit, Boe Sandahl Sorensen, Jens Kelsen
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background and aims Studies suggest that mutations in the CTNNB1 gene are predictive of response to immunotherapy, an emerging therapy for advanced hepatocellular carcinoma (HCC). Analysis of circulating tumor DNA (ctDNA) offers the possibil
Externí odkaz:
https://doaj.org/article/d55854123f184e32a815ea076f23f8ec
Autor:
Monika Lewinska, PhD, Alvaro Santos-Laso, PhD, Enara Arretxe, PhD, Cristina Alonso, PhD, Ekaterina Zhuravleva, PhD, Raul Jimenez-Agüero, MD, PhD, Emma Eizaguirre, MD, PhD, María Jesús Pareja, MD, PhD, Manuel Romero-Gómez, MD, PhD, Marco Arrese Jimenez, MD, PhD, Malte P. Suppli, MD, PhD, Filip K. Knop, MD, PhD, Stine Karlsen Oversoe, MD, PhD, Gerda Elisabeth Villadsen, MD, PhD, Thomas Decaens, MD, PhD, Flair Jose Carrilho, MD, PhD, Claudia PMS de Oliveira, MD, PhD, Bruno Sangro, MD, PhD, Rocio I.R. Macias, MD, PhD, Jesus M. Banales, PhD, Jesper B. Andersen, PhD
Publikováno v:
EBioMedicine, Vol 73, Iss , Pp 103661- (2021)
Background: Non-alcoholic fatty liver disease (NAFLD) is affecting more people globally. Indeed, NAFLD is a spectrum of metabolic dysfunctions that can progress to hepatocellular carcinoma (NAFLD-HCC). This development can occur in a non-cirrhotic li
Externí odkaz:
https://doaj.org/article/a98663c5714b4b39a2da1a493b1539b3
Autor:
Oversoe, Stine Karlsen1,2 (AUTHOR) stinkarl@rm.dk, Clement, Michelle Simone3 (AUTHOR), Weber, Britta4 (AUTHOR), Grønbæk, Henning1 (AUTHOR), Hamilton-Dutoit, Stephen Jacques5 (AUTHOR), Sorensen, Boe Sandahl3 (AUTHOR), Kelsen, Jens1 (AUTHOR)
Publikováno v:
BMC Cancer. 4/7/2021, Vol. 21 Issue 1, p1-7. 7p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Henning Grønbæk, Stephen Hamilton-Dutoit, Michelle Simone Clement, Stine Karlsen Oversoe, Britta Weber, Boe Sandahl Sorensen, Jens Kelsen
Publikováno v:
BMC Cancer
Oversoe, S K, Clement, M S, Weber, B, Grønbæk, H, Hamilton-Dutoit, S J, Sorensen, B S & Kelsen, J 2021, ' Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma ', BMC Cancer, vol. 21, no. 1, 376 . https://doi.org/10.1186/s12885-021-08103-0
BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)
Oversoe, S K, Clement, M S, Weber, B, Grønbæk, H, Hamilton-Dutoit, S J, Sorensen, B S & Kelsen, J 2021, ' Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma ', BMC Cancer, vol. 21, no. 1, 376 . https://doi.org/10.1186/s12885-021-08103-0
BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)
Background and aims Studies suggest that mutations in the CTNNB1 gene are predictive of response to immunotherapy, an emerging therapy for advanced hepatocellular carcinoma (HCC). Analysis of circulating tumor DNA (ctDNA) offers the possibility of se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f089cd53672980a86e57b42437499b7
http://europepmc.org/articles/PMC8028749
http://europepmc.org/articles/PMC8028749
Autor:
Raul Jimenez-Agüero, Monika Lewinska, Alvaro Santos-Laso, Bruno Sangro, Enara Arrretxe, Malte P. Suppli, Stine Karlsen Oversoe, Claudia P. Oliveira, Filip K. Knop, Jesper B. Andersen, Flair José Carrilho, Rocio I.R. Macias, Emma Eizaguirre, Jesus M. Banales, Thomas Decaens, Cristina Alonso, Marco Arrese, Manuel Romero-Gómez, Gerda Elisabeth Villadsen, María Jesús Pareja
Metabolic-associated fatty liver disease (MAFLD) is affecting more people globally. Indeed, MAFLD is associated with a spectrum of metabolic dysfunctions that can progress to hepatocellular carcinoma (MAFLD-HCC). This development can occur in a non-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfba818ab38ffdcdf8387bb0a778e445
https://doi.org/10.21203/rs.3.rs-140974/v1
https://doi.org/10.21203/rs.3.rs-140974/v1
Autor:
Malte P. Suppli, Cristina Alonso, Bruno Sangro, Ekaterina Zhuravleva, Rocio I.R. Macias, Filip K. Knop, Emma Eizaguirre, Manuel Romero-Gómez, Jesus M. Banales, Alvaro Santos-Laso, Raul Jimenez-Agüero, Jesper B. Andersen, Marco Arrese Jimenez, Monika Lewinska, Stine Karlsen Oversoe, Flair José Carrilho, Gerda Elisabeth Villadsen, María Jesús Pareja, Claudia Pms de Oliveira, Thomas Decaens, Enara Arretxe
Publikováno v:
EBioMedicine, Vol 73, Iss, Pp 103661-(2021)
Lewinska, M, Santos-Laso, A, Arretxe, E, Alonso, C, Zhuravleva, E, Jimenez-Agüero, R, Eizaguirre, E, Pareja, M J, Romero-Gómez, M, Arrese, M, Suppli, M P, Knop, F K, Oversoe, S K, Villadsen, G E, Decaens, T, Carrilho, F J, de Oliveira, C P, Sangro, B, Macias, R I R, Banales, J M & Andersen, J B 2021, ' The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma ', EBioMedicine, vol. 73, pp. 103661 . https://doi.org/10.1016/j.ebiom.2021.103661
Addi. Archivo Digital para la Docencia y la Investigación
instname
EBioMedicine
Digital.CSIC. Repositorio Institucional del CSIC
Lewinska, M, Santos-Laso, A, Arretxe, E, Alonso, C, Zhuravleva, E, Jimenez-Agüero, R, Eizaguirre, E, Pareja, M J, Romero-Gómez, M, Arrese, M, Suppli, M P, Knop, F K, Oversoe, S K, Villadsen, G E, Decaens, T, Carrilho, F J, de Oliveira, C P, Sangro, B, Macias, R I R, Banales, J M & Andersen, J B 2021, ' The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma ', EBioMedicine, vol. 73, pp. 103661 . https://doi.org/10.1016/j.ebiom.2021.103661
Addi. Archivo Digital para la Docencia y la Investigación
instname
EBioMedicine
Digital.CSIC. Repositorio Institucional del CSIC
[Background] Non-alcoholic fatty liver disease (NAFLD) is affecting more people globally. Indeed, NAFLD is a spectrum of metabolic dysfunctions that can progress to hepatocellular carcinoma (NAFLD-HCC). This development can occur in a non-cirrhotic l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4da069c4db0add797224a1fd8ecbf5f1
https://doi.org/10.2139/ssrn.3894905
https://doi.org/10.2139/ssrn.3894905
Autor:
Oversoe, Stine Karlsen, Clement, Michelle Simone, Weber, Britta, Grønbæk, Henning, Hamilton-Dutoit, Stephen Jacques, Boe Sandahl Sorensen, Kelsen, Jens
Additional file 1. Droplet digital PCR analysis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a61f976fa5a3899e64f85cc840a00ffe
Autor:
Lewinska, Monika, Santos-Laso, Alvaro, Arretxe, Enara, Alonso, Cristina, Zhuravleva, Ekaterina, Jimenez-Agüero, Raul, Eizaguirre, Emma, Pareja, María Jesús, Romero-Gómez, Manuel, Jimenez, Marco Arrese, Suppli, Malte P., Knop, Filip K., Oversoe, Stine Karlsen, Villadsen, Gerda Elisabeth, Decaens, Thomas, Carrilho, Flair Jose, de Oliveira, Claudia PMS, Sangro, Bruno, Macias, Rocio I.R., Banales, Jesus M., Andersen, Jesper B.
Publikováno v:
Lewinska, M, Santos-Laso, A, Arretxe, E, Alonso, C, Zhuravleva, E, Jimenez-Agüero, R, Eizaguirre, E, Pareja, M J, Romero-Gómez, M, Jimenez, M A, Suppli, M P, Knop, F K, Oversoe, S K, Villadsen, G E, Decaens, T, Carrilho, F J, de Oliveira, C PMS, Sangro, B, Macias, R I R, Banales, J M & Andersen, J B 2021, ' The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma : Diagnosis of NAFLD-HCC utilising serum lipidomics ', EBioMedicine, vol. 73, 103661 . https://doi.org/10.1016/j.ebiom.2021.103661
Background: Non-alcoholic fatty liver disease (NAFLD) is affecting more people globally. Indeed, NAFLD is a spectrum of metabolic dysfunctions that can progress to hepatocellular carcinoma (NAFLD-HCC). This development can occur in a non-cirrhotic li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cf04f0b29d98d09c778afa1fd92ea402
https://curis.ku.dk/portal/da/publications/the-altered-serum-lipidome-and-its-diagnostic-potential-for-nonalcoholic-fatty-liver-naflassociated-hepatocellular-carcinoma(921c8a24-5c18-4df4-8c0f-6bbd95fa4093).html
https://curis.ku.dk/portal/da/publications/the-altered-serum-lipidome-and-its-diagnostic-potential-for-nonalcoholic-fatty-liver-naflassociated-hepatocellular-carcinoma(921c8a24-5c18-4df4-8c0f-6bbd95fa4093).html
Publikováno v:
Transplantation Proceedings
Mathiasen, V D, Oversoe, S K, Ott, P, Jensen-Fangel, S & Leth, S 2020, ' Recovery of Moderate Coronavirus Disease 2019 in a Liver Transplant Recipient on Continued Immunosuppression : A Case Report ', Transplantation Proceedings, vol. 52, no. 9, pp. 2703-2706 . https://doi.org/10.1016/j.transproceed.2020.09.007
Mathiasen, V D, Oversoe, S K, Ott, P, Jensen-Fangel, S & Leth, S 2020, ' Recovery of Moderate Coronavirus Disease 2019 in a Liver Transplant Recipient on Continued Immunosuppression : A Case Report ', Transplantation Proceedings . https://doi.org/10.1016/j.transproceed.2020.09.007
Mathiasen, V D, Oversoe, S K, Ott, P, Jensen-Fangel, S & Leth, S 2020, ' Recovery of Moderate Coronavirus Disease 2019 in a Liver Transplant Recipient on Continued Immunosuppression : A Case Report ', Transplantation Proceedings, vol. 52, no. 9, pp. 2703-2706 . https://doi.org/10.1016/j.transproceed.2020.09.007
Mathiasen, V D, Oversoe, S K, Ott, P, Jensen-Fangel, S & Leth, S 2020, ' Recovery of Moderate Coronavirus Disease 2019 in a Liver Transplant Recipient on Continued Immunosuppression : A Case Report ', Transplantation Proceedings . https://doi.org/10.1016/j.transproceed.2020.09.007
The global outbreak of severe acute respiratory syndrome coronavirus 2 has had an enormous impact on the world. It remains unclear to what extent liver transplant recipients should be considered at a higher risk of severe disease due to the limited d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2db3659e727edb21bf0630f3f3d5aa7